SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mesco Pharmaceuticals to hold board meeting

05 Nov 2020 Evaluate

Mesco Pharmaceuticals has informed that pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company will be held on Thursday, 12th November, 2020 at New Delhi, to consider and approve the standalone unaudited financial results for the quarter ended on 30th September, 2020, along with Limited Review Reports; and any other item, if any, with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Mesco Pharma Share Price

4.54 0.00 (0.00%)
10-Jan-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1871.55
Dr. Reddys Labs. 1346.25
Cipla 1456.25
Zydus Lifesciences 1099.65
Lupin 2398.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: